Cibus to Report Third Quarter 2023 Financial Results on November 9, 2023 and Host Conference Call
November 02 2023 - 4:05PM
Cibus, Inc. (Nasdaq: CBUS), a global leader in gene editing in
agriculture and the development of productivity traits in plants,
today announced that the Company will report third quarter 2023
financial results on Thursday, November 9, 2023. Cibus’ management
team will host a conference call and audio webcast at 4:30 p.m. ET
on that day to discuss the financial results and other company
updates.
Title: Cibus, Inc. Third Quarter 2023 Results Conference
CallEvent Date: Thursday, November 9, 2023Time: 4:30 p.m.
ETParticipant Numbers: +1-877-243-8548 (U.S.), +1-312-281-2974
(International)Event Link: https://investor.cibus.com/events
For interested individuals unable to join the conference call, a
dial-in replay of the call will be available through Thursday,
November 23, 2023 and can be accessed by dialing +1-844-512-2921
(U.S.), +1-412-317-6671 (International) and entering replay
passcode: 22028314.
A live audio webcast of the call, along with accompanying
slides, will be available under "News & Events” in the Investor
section of the Company's website, investor.cibus.com. An archived
webcast will be available on the Company's website for 90 days
after the event.
About Cibus
Cibus is a leader in gene edited productivity traits that
address critical productivity and sustainability areas for farmers
such as diseases and pests which the United Nations estimates cost
the global economy approximately $300 billion annually. Cibus is
not a seed company. It is a technology company that develops and
licenses traits to leading seed companies. Cibus’ focus is
developing scale, multi-crop traits in the major global crops such
as canola, rice, and soybean. Traits that can make a real impact in
global agricultural productivity. Cibus is the technology leader in
high throughput gene editing technology with its Trait Machine™
process. It enables Cibus to develop plant traits precisely and
predictably at a fraction of the time and cost of conventional
breeding. Cibus has developed a pipeline of five productivity
traits including important traits for pod shatter reduction,
disease resistance, and weed management. Its initial traits for pod
shatter reduction and weed management are developed and are in
commercial collaborations with leading seed companies. Its other
pipeline traits, including Sclerotinia resistance, are in advanced
greenhouse and field trial stages.
Cibus Contacts:
Investor Relations Karen
Troeberktroeber@cibus.com 858-450-2636
Jeff Sonnek – ICR jeff.sonnek@icrinc.com
Media RelationsColin Sanford
colin@bioscribe.com 203-918-4347
Cibus (NASDAQ:CBUS)
Historical Stock Chart
From Apr 2024 to May 2024
Cibus (NASDAQ:CBUS)
Historical Stock Chart
From May 2023 to May 2024